Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Clinical Senior Lecturer in Interstitial Lung Disease







Sir Alexander Fleming BuildingSouth Kensington Campus





Dr Philip Molyneaux is a Clinical Senior Lecturer in Interstitial lung disease and an Honorary Consultant at the Royal Brompton Hospital, where he is the director of the Clinical Research Facility.

Philip qualified from Guy's, King's and St Thomas' School of Medicine in 2004, where he completed an intercalated BSc. in Molecular Genetics. He undertook his SHO training at Guy’s and St Thomas’ and upon completion of the MRCP attained an NIHR Academic Clinical Fellow position in Respiratory medicine at Imperial College. He spent the next two years training at St Mary’s Hospital and working with Professors Cookson, Moffatt and Johnston studying the respiratory microbiome in COPD. 

An Asmarley training fellowship allowed him to undertake a PhD examining the host response to the respiratory microbiome in Idiopathic Pulmonary Fibrosis as part of the Prospective Study of Fibrosis In the Lung Endpoints (PROFILE) study with Professor Maher.

Having completed his clinical training in Respiratory and Critical Care Medicine he returned to Imperial joining the Fibrosis Research Group as a Senior Clinical Lecturer. He was awarded the Action for Pulmonary Fibrosis Mike Bray Fellowship which enabled him to establish his research group studying the interaction between the respiratory tract microbiota and innate immunity in pulmonary fibrosis. He is Associate Editor at European Respiratory Journal Open Research and BMC Pulmonary Medicine. He sits on the British Thoracic Society Science and Advisory board as well as the ILD Registry committee.



Ogger PP, Albers GJ, Hewitt RJ, et al., 2020, Itaconate controls the severity of pulmonary fibrosis., Science Immunology, Vol:5, ISSN:2470-9468, Pages:1-13

Drake TM, Docherty AB, Harrison EM, et al., 2020, Outcome of hospitalization for COVID-19 in patients with interstitial lung disease: an international multicenter study., American Journal of Respiratory and Critical Care Medicine, ISSN:1073-449X

Stock CJ, Conti C, Montero-Fernandez Á, et al., 2020, Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?, Thorax, Vol:75, ISSN:0040-6376, Pages:901-903

Zhang YZ, Brambilla C, Molyneaux PL, et al., 2020, Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2-tier nuclear grade, Histopathology, Vol:77, ISSN:0309-0167, Pages:423-436

George PM, Spagnolo P, Kreuter M, et al., 2020, Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities., The Lancet Respiratory Medicine, Vol:8, ISSN:2213-2600, Pages:925-934

More Publications